Company Filing History:
Years Active: 2021-2025
Title: Innovations of Inventor Xin Gan
Introduction
Xin Gan is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of two patents to his name, his work focuses on innovative treatments for various diseases.
Latest Patents
Xin Gan's latest patents include groundbreaking research on antibodies binding to CTLA-4. These patents disclose isolated monoclonal antibodies that comprise a CD152-binding domain, specifically targeting human CD152. The methods outlined in these patents provide new avenues for treating diseases, including cancers and autoimmune disorders.
Career Highlights
Throughout his career, Xin Gan has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Harbour Biomed (Shanghai) Co., Ltd. and Harbour Biomed Co., Ltd. His work in these organizations has contributed to advancements in therapeutic solutions.
Collaborations
Xin Gan has collaborated with several professionals in his field, including Yun He and Yuqiang Shen. These collaborations have fostered a productive environment for innovation and research.
Conclusion
In summary, Xin Gan is a distinguished inventor whose work on monoclonal antibodies has the potential to revolutionize treatments for serious health conditions. His contributions to biotechnology continue to pave the way for future innovations.